Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Unknown

Evaluation of the Impact of Pancreatectomy on Systemic Immunity

Pancreatic Surgery: Evaluation of the Impact of Pancreatectomy on Systemic Immunity

Outcome
Outcome unknown
Phase
No phase (not a drug trial)
Status
Unknown
Study type
Interventional
Start
24 February 2021
Listed end
27 July 2022
Enrollment
40 participants
Sites
1
Primary outcomes
Measurement of immune effectors (Tcells, NK) levels after pancreatectomy
Sponsor type
Academic / other
Results posted
No
Last update
6 January 2022

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

The study aims at establishing the profile of the immune reaction that occurs in the early surgical suites after pancreatectomy. Blood samples will be collected before surgery, (Day-1), at day0, and after surgery at Day 1, Day 3, Day 7 at 1 year after pancreatectomy. Mass cytometry, genomic and transcriptomic approaches will be used to evaluate the immune systemic modulation after surgery.